InvestorsHub Logo

jour_trader

10/21/23 11:35 AM

#389686 RE: Pharma Sleuth #389680

Lol that’s what I thought. You simply stated to ignore R&D. In all acquisitions of which I have been a part, R&D has Never been ignored. Not once.

If there’s a benefit, it’s a synergy, but not excluded when taking into consideration from an acquisition or forward multiple standpoint.

Thanks for admitting you have zero experience in this space. Sit back down and pretend like you do from your computer.